Stocks and Investing Stocks and Investing
Wed, March 6, 2024
Tue, March 5, 2024

Gregory Renza Reiterated (SPRB) at Buy and Held Target at $9 on, Mar 5th, 2024


Published on 2024-10-28 09:28:07 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Reiterated "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $9 on, Mar 5th, 2024.

Gregory has made no other calls on SPRB in the last 4 months.



There are 2 other peers that have a rating on SPRB. Out of the 2 peers that are also analyzing SPRB, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Gregory


  • Evan Wang of "Guggenheim" Initiated at Strong Buy and Held Target at $10 on, Wednesday, February 21st, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Monday, November 20th, 2023
Contributing Sources